EMA
guidance
· 2022-09-30
New recommendations for terlipressin-containing medicines in the treatment of hepatorenal syndrome
Summary
EMA issued new recommendations regarding terlipressin-containing medicines used to treat hepatorenal syndrome, outlining updated safety and usage guidelines.
Upgrade for the full analysis, importance score, and drug timeline.